Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genomic and transmission dynamics of the 2024 Marburg virus outbreak in Rwanda.
Butera Y, Mutesa L, Parker E, Muvunyi R, Umumararungu E, Ayitewala A, Musabyimana JP, Olono A, Sesonga P, Ogunsanya O, Kabalisa E, Adedokun O, Gahima N, Irankunda L, Mutezemariya C, Niyonkuru R, Uwituze A, Uwizera I, Kagame J, Umugwaneza A, Rwabuhihi J, Umwanankabandi F, Mbonitegeka V, Ntagwabira E, Kayigi E, Izuwayo G, Murenzi H, Mukankwiro T, Tuyiringire N, Uwimana JMV, Gasengayire A, Sindayiheba R, Onyeugo GU, Aragaw M, Gitundu L, Bigirimana R, Fallah M, Ejikeme A, Sembuche S, Kabanda A, Mugisha JC, Francis EES, Gashema P, Ndayisenga J, Rugamba A, Kanyabwisha F, Murenzi G, Happi A, Ngabonziza JCS, Gashegu M, Ahmed A, Bigirimana N, Rwagasore E, Semakula M, Rwabihama JP, Musanabaganwa C, Seruyange E, Nkeshimana M, Twagirumugabe T, Turatsinze D, Remera E, Gahamanyi N, Tessema SK, Mukagatare I, Nsanzimana S, Happi C, Muvunyi CM. Butera Y, et al. Among authors: ngabonziza jcs. Nat Med. 2024 Dec 16. doi: 10.1038/s41591-024-03459-9. Online ahead of print. Nat Med. 2024. PMID: 39681304
Highly successful treatment outcome of multidrug-resistant and genetic diversity of multidrug-resistant Mycobacterium tuberculosis strains in Rwanda.
Muvunyi CM, Ngabonziza JCS, Uwimana I, Harelimana JD, Mucyo Y, Sebatunzi OR, Muvunyi TZ, Seruyange E, Masaisa F, Mazarati JB, Gasana M. Muvunyi CM, et al. Among authors: ngabonziza jcs. Trop Med Int Health. 2019 Jul;24(7):879-887. doi: 10.1111/tmi.13245. Epub 2019 Jun 3. Trop Med Int Health. 2019. PMID: 31066112 Free article.
Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trial.
Snobre J, Gasana J, Ngabonziza JCS, Cuella-Martin I, Rigouts L, Jacobs BK, de Viron E, Herssens N, Ntihumby JB, Klibazayre A, Ndayishimiye C, Van Deun A, Affolabi D, Merle CS, Muvunyi C, Sturkenboom MGG, Migambi P, de Jong BC, Mucyo Y, Decroo T. Snobre J, et al. Among authors: ngabonziza jcs. BMJ Open. 2024 Jul 24;14(7):e078379. doi: 10.1136/bmjopen-2023-078379. BMJ Open. 2024. PMID: 39053960 Free PMC article.
Predictors of Rifampicin-Resistant Tuberculosis Mortality among HIV-Coinfected Patients in Rwanda.
Habimana DS, Ngabonziza JCS, Migambi P, Mucyo-Habimana Y, Mutembayire G, Byukusenge F, Habiyambere I, Remera E, Mugwaneza P, Mwikarago IE, Mazarati JB, Turate I, Nsanzimana S, Decroo T, de Jong CB. Habimana DS, et al. Among authors: ngabonziza jcs. Am J Trop Med Hyg. 2021 May 17;105(1):47-53. doi: 10.4269/ajtmh.20-1361. Am J Trop Med Hyg. 2021. PMID: 33999845 Free PMC article.
Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda.
Ngabonziza JCS, Decroo T, Migambi P, Habimana YM, Van Deun A, Meehan CJ, Torrea G, Massou F, de Rijk WB, Ushizimpumu B, Niyigena EB, Ivan E, Semahore JM, Mazarati JB, Merle CS, Supply P, Affolabi D, Rigouts L, de Jong BC. Ngabonziza JCS, et al. Lancet Microbe. 2020 Jun;1(2):e74-e83. doi: 10.1016/S2666-5247(20)30007-0. Epub 2020 Jun 8. Lancet Microbe. 2020. PMID: 35544156 Free article.
23 results